M72.4 Pseudosarcomatous fibromatosis

Name of the Condition

• Pseudosarcomatous fibromatosis

Summary

Pseudosarcomatous fibromatosis is a benign fibroblastic condition characterized by the proliferation of fibrous tissue that may mimic sarcoma due to its cellular appearance. It typically presents as a firm, painless mass in soft tissues, often involving the subcutaneous or deep fascial layers. The condition is non-malignant but may cause local symptoms or functional impairment depending on its location and size.

Causes

The exact etiology of pseudosarcomatous fibromatosis is not fully understood. It may arise from abnormal fibroblast activity, dysregulated wound healing, or a reactive process to prior trauma, inflammation, or surgery. Some cases are associated with repetitive mechanical stress or underlying systemic conditions, though no specific trigger is consistently identified.

Risk Factors

• Age: More common in middle-aged to older adults.
• Gender: Slight male predominance in some case series.
• Trauma or surgery: Prior injury or surgical intervention to the affected area.
• Chronic irritation: Repeated mechanical stress or inflammation.
• Genetic predisposition: Potential association with familial fibromatoses.

Symptoms

• Firm, palpable mass in soft tissues.
• Localized pain or discomfort, especially with movement.
• Restricted range of motion if near joints or tendons.
• Gradual enlargement over weeks to months.
• Skin changes (e.g., tethering or dimpling) in superficial lesions.

Diagnosis

Diagnosis relies on clinical evaluation and histopathological examination. Imaging (ultrasound, MRI) may be used to assess the extent of the lesion and rule out malignancy. A biopsy is typically performed to confirm the diagnosis, as the cellular appearance can resemble sarcoma. Correlation with clinical context is essential to avoid misclassification.

Treatment Options

• Observation: For asymptomatic or slow-growing lesions.
• Surgical excision: Definitive treatment for symptomatic or enlarging masses.
• Corticosteroid injections: To reduce inflammation in select cases.
• Physical therapy: To maintain mobility and manage discomfort.

Prognosis and Follow-Up

Pseudosarcomatous fibromatosis is benign with an excellent prognosis after complete excision. Recurrence is uncommon but may occur in a small percentage of cases. Follow-up typically involves periodic clinical exams to monitor for regrowth or new lesions, especially if the initial lesion was large or incompletely excised.

Complications

• Local recurrence (rare).
• Functional impairment due to mass effect on adjacent structures.
• Misdiagnosis as malignancy, leading to unnecessary aggressive treatment.

Lifestyle & Prevention

No specific preventive measures are known. Avoiding repetitive trauma or excessive stress to affected areas may reduce risk in susceptible individuals. Early evaluation of new or enlarging masses is recommended to facilitate timely diagnosis and management.

When to Seek Professional Help

Seek medical attention if a new, firm mass develops, especially if it grows rapidly, causes pain, or limits movement. Prompt evaluation is important to rule out malignancy and initiate appropriate treatment.

Tips for Medical Coders

Code M72.4 is specific to pseudosarcomatous fibromatosis. Documentation should include the location of the lesion, clinical findings (e.g., mass, pain), and any diagnostic procedures (e.g., biopsy, imaging). Ensure the term "pseudosarcomatous fibromatosis" is clearly documented to support accurate coding. Differentiate from other fibromatoses (e.g., palmar or plantar) by specifying the anatomical site.